New drug OVV-01 injected into tumors shows promise in early trial
Disease control
Recruiting now
This early-phase study is testing a new drug called OVV-01 in 18 people with advanced solid tumors that have not responded to standard treatments. The drug is given either through a vein or directly into a tumor. The main goal is to check safety and find the right dose, while als…
Phase: PHASE1 • Sponsor: Joint Biosciences Ltd. • Aim: Disease control
Last updated Jun 22, 2026 11:56 UTC